# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-003492
Filing Date
2024-02-06
Accepted
2024-02-06 16:13:48
Documents
178
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | arwr-20231231.htm iXBRL | 10-Q | 909638
2 | EX-10.1 | gsk-amendedandrestatedli.htm | EX-10.1 | 336294
3 | EX-31.1 | arwr-20231231xex311.htm | EX-31.1 | 628
4 | EX-31.2 | arwr-20231231xex312.htm | EX-31.2 | 628
5 | EX-32.1 | arwr-20231231xex321.htm | EX-32.1 | 628
6 | EX-32.2 | arwr-20231231xex322.htm | EX-32.2 | 628
12 |  | arwr-20231231xex311001.jpg | GRAPHIC | 212781
13 |  | arwr-20231231xex312001.jpg | GRAPHIC | 210335
14 |  | arwr-20231231xex321001.jpg | GRAPHIC | 91426
15 |  | arwr-20231231xex322001.jpg | GRAPHIC | 87332
16 |  | gsk-amendedandrestatedli001.jpg | GRAPHIC | 272359
17 |  | gsk-amendedandrestatedli002.jpg | GRAPHIC | 233901
18 |  | gsk-amendedandrestatedli003.jpg | GRAPHIC | 217274
19 |  | gsk-amendedandrestatedli004.jpg | GRAPHIC | 273578
20 |  | gsk-amendedandrestatedli005.jpg | GRAPHIC | 247420
21 |  | gsk-amendedandrestatedli006.jpg | GRAPHIC | 286977
22 |  | gsk-amendedandrestatedli007.jpg | GRAPHIC | 290691
23 |  | gsk-amendedandrestatedli008.jpg | GRAPHIC | 287062
24 |  | gsk-amendedandrestatedli009.jpg | GRAPHIC | 269376
25 |  | gsk-amendedandrestatedli010.jpg | GRAPHIC | 255740
26 |  | gsk-amendedandrestatedli011.jpg | GRAPHIC | 273563
27 |  | gsk-amendedandrestatedli012.jpg | GRAPHIC | 278286
28 |  | gsk-amendedandrestatedli013.jpg | GRAPHIC | 277223
29 |  | gsk-amendedandrestatedli014.jpg | GRAPHIC | 265428
30 |  | gsk-amendedandrestatedli015.jpg | GRAPHIC | 266250
31 |  | gsk-amendedandrestatedli016.jpg | GRAPHIC | 257174
32 |  | gsk-amendedandrestatedli017.jpg | GRAPHIC | 239849
33 |  | gsk-amendedandrestatedli018.jpg | GRAPHIC | 315806
34 |  | gsk-amendedandrestatedli019.jpg | GRAPHIC | 248045
35 |  | gsk-amendedandrestatedli020.jpg | GRAPHIC | 258947
36 |  | gsk-amendedandrestatedli021.jpg | GRAPHIC | 252077
37 |  | gsk-amendedandrestatedli022.jpg | GRAPHIC | 266902
38 |  | gsk-amendedandrestatedli023.jpg | GRAPHIC | 308595
39 |  | gsk-amendedandrestatedli024.jpg | GRAPHIC | 265092
40 |  | gsk-amendedandrestatedli025.jpg | GRAPHIC | 230275
41 |  | gsk-amendedandrestatedli026.jpg | GRAPHIC | 249938
42 |  | gsk-amendedandrestatedli027.jpg | GRAPHIC | 294732
43 |  | gsk-amendedandrestatedli028.jpg | GRAPHIC | 313006
44 |  | gsk-amendedandrestatedli029.jpg | GRAPHIC | 273235
45 |  | gsk-amendedandrestatedli030.jpg | GRAPHIC | 245228
46 |  | gsk-amendedandrestatedli031.jpg | GRAPHIC | 288487
47 |  | gsk-amendedandrestatedli032.jpg | GRAPHIC | 288848
48 |  | gsk-amendedandrestatedli033.jpg | GRAPHIC | 292543
49 |  | gsk-amendedandrestatedli034.jpg | GRAPHIC | 299687
50 |  | gsk-amendedandrestatedli035.jpg | GRAPHIC | 279032
51 |  | gsk-amendedandrestatedli036.jpg | GRAPHIC | 297545
52 |  | gsk-amendedandrestatedli037.jpg | GRAPHIC | 309856
53 |  | gsk-amendedandrestatedli038.jpg | GRAPHIC | 200727
54 |  | gsk-amendedandrestatedli039.jpg | GRAPHIC | 186941
55 |  | gsk-amendedandrestatedli040.jpg | GRAPHIC | 269109
56 |  | gsk-amendedandrestatedli041.jpg | GRAPHIC | 237455
57 |  | gsk-amendedandrestatedli042.jpg | GRAPHIC | 269212
58 |  | gsk-amendedandrestatedli043.jpg | GRAPHIC | 239021
59 |  | gsk-amendedandrestatedli044.jpg | GRAPHIC | 242626
60 |  | gsk-amendedandrestatedli045.jpg | GRAPHIC | 282895
61 |  | gsk-amendedandrestatedli046.jpg | GRAPHIC | 282857
62 |  | gsk-amendedandrestatedli047.jpg | GRAPHIC | 281622
63 |  | gsk-amendedandrestatedli048.jpg | GRAPHIC | 262092
64 |  | gsk-amendedandrestatedli049.jpg | GRAPHIC | 244311
65 |  | gsk-amendedandrestatedli050.jpg | GRAPHIC | 239666
66 |  | gsk-amendedandrestatedli051.jpg | GRAPHIC | 240031
67 |  | gsk-amendedandrestatedli052.jpg | GRAPHIC | 252819
68 |  | gsk-amendedandrestatedli053.jpg | GRAPHIC | 265080
69 |  | gsk-amendedandrestatedli054.jpg | GRAPHIC | 269727
70 |  | gsk-amendedandrestatedli055.jpg | GRAPHIC | 266507
71 |  | gsk-amendedandrestatedli056.jpg | GRAPHIC | 234205
72 |  | gsk-amendedandrestatedli057.jpg | GRAPHIC | 255134
73 |  | gsk-amendedandrestatedli058.jpg | GRAPHIC | 259157
74 |  | gsk-amendedandrestatedli059.jpg | GRAPHIC | 299415
75 |  | gsk-amendedandrestatedli060.jpg | GRAPHIC | 301257
76 |  | gsk-amendedandrestatedli061.jpg | GRAPHIC | 291033
77 |  | gsk-amendedandrestatedli062.jpg | GRAPHIC | 211938
78 |  | gsk-amendedandrestatedli063.jpg | GRAPHIC | 279254
79 |  | gsk-amendedandrestatedli064.jpg | GRAPHIC | 233669
80 |  | gsk-amendedandrestatedli065.jpg | GRAPHIC | 299052
81 |  | gsk-amendedandrestatedli066.jpg | GRAPHIC | 268185
82 |  | gsk-amendedandrestatedli067.jpg | GRAPHIC | 264843
83 |  | gsk-amendedandrestatedli068.jpg | GRAPHIC | 274952
84 |  | gsk-amendedandrestatedli069.jpg | GRAPHIC | 269776
85 |  | gsk-amendedandrestatedli070.jpg | GRAPHIC | 257019
86 |  | gsk-amendedandrestatedli071.jpg | GRAPHIC | 293385
87 |  | gsk-amendedandrestatedli072.jpg | GRAPHIC | 296706
88 |  | gsk-amendedandrestatedli073.jpg | GRAPHIC | 316810
89 |  | gsk-amendedandrestatedli074.jpg | GRAPHIC | 297542
90 |  | gsk-amendedandrestatedli075.jpg | GRAPHIC | 266645
91 |  | gsk-amendedandrestatedli076.jpg | GRAPHIC | 263245
92 |  | gsk-amendedandrestatedli077.jpg | GRAPHIC | 281396
93 |  | gsk-amendedandrestatedli078.jpg | GRAPHIC | 279432
94 |  | gsk-amendedandrestatedli079.jpg | GRAPHIC | 287971
95 |  | gsk-amendedandrestatedli080.jpg | GRAPHIC | 286575
96 |  | gsk-amendedandrestatedli081.jpg | GRAPHIC | 269019
97 |  | gsk-amendedandrestatedli082.jpg | GRAPHIC | 242343
98 |  | gsk-amendedandrestatedli083.jpg | GRAPHIC | 283551
99 |  | gsk-amendedandrestatedli084.jpg | GRAPHIC | 276823
100 |  | gsk-amendedandrestatedli085.jpg | GRAPHIC | 326119
101 |  | gsk-amendedandrestatedli086.jpg | GRAPHIC | 275561
102 |  | gsk-amendedandrestatedli087.jpg | GRAPHIC | 258053
103 |  | gsk-amendedandrestatedli088.jpg | GRAPHIC | 282220
104 |  | gsk-amendedandrestatedli089.jpg | GRAPHIC | 286452
105 |  | gsk-amendedandrestatedli090.jpg | GRAPHIC | 199220
106 |  | gsk-amendedandrestatedli091.jpg | GRAPHIC | 288325
107 |  | gsk-amendedandrestatedli092.jpg | GRAPHIC | 313069
108 |  | gsk-amendedandrestatedli093.jpg | GRAPHIC | 323201
109 |  | gsk-amendedandrestatedli094.jpg | GRAPHIC | 83217
110 |  | gsk-amendedandrestatedli095.jpg | GRAPHIC | 58479
111 |  | gsk-amendedandrestatedli096.jpg | GRAPHIC | 23673
| Complete submission text file | 0001628280-24-003492.txt |  | 42288282

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | arwr-20231231.xsd | EX-101.SCH | 51835
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | arwr-20231231_cal.xml | EX-101.CAL | 70540
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | arwr-20231231_def.xml | EX-101.DEF | 236831
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | arwr-20231231_lab.xml | EX-101.LAB | 664074
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | arwr-20231231_pre.xml | EX-101.PRE | 451062
179 | EXTRACTED XBRL INSTANCE DOCUMENT | arwr-20231231_htm.xml | XML | 828478

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 24600419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)